We are pleased to announce that the 2019 North American Cannabis Summit will address the increasingly important role of monitoring and survelliance in relation to cannabis legislation and public health.
Gillian Schauer is coordinating and will participate in a keynote panel on state, national, and international efforts to collect, analyze, and interpret cannabis use data for informing public health policy. Anyone seeking to develop a robust surveillance system will not want to miss this opportunity for objective and experience-based guidance.
Dr. Gillian Schauer is a senior consultant to the National Institute on Drug Abuse (NIDA) and the Centers for Disease Control and Prevention (CDC), working on cannabis and tobacco policy, research, and survelliance issues. She has also been a senior policy fellow at the CDC Foundation, where her work focused on cannabis survellience, policy tracking, research, and state public health technical assistance, including founding the Multi-State Collabortive on Cannabis and Public Health that convenes health officers, epidemiologists, and other health professionals from adult use states.
Dr. Schauer has more than 15 years of experience in substance use and health systems-related work. She is a clinical instructor at the University of Washington (UW) in the Department of Health Services and a co-instructor in the UW Tobacco Studies Program. Dr. Schauer’s research has focused on cannabis policy and patterns of use, co-use of marijuana and tobacco cessation, and health systems transformation. She has more than 50 peer-reviewed publications on these topics to her credit.